Patents by Inventor Joel W. Slaton

Joel W. Slaton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Casein kinase 2 antisense therapy
    Patent number: 7741304
    Abstract: The invention provides for antisense oligonucleotides that hybridize to casein kinase 2 nucleic acid sequences and methods of using such antisense oligonucleotides to inhibit expression of casein kinase 2 and reduce the size of solid tumors.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: June 22, 2010
    Assignee: Regents of The University of Minnesota
    Inventors: Joel W. Slaton, Khalil Ahmed, Gretchen M. Unger, Alan Davis, Dan Sloper
  • CASEIN KINASE 2 ANTISENSE THERAPY
    Publication number: 20080113932
    Abstract: The invention provides for antisense oligonucleotides that hybridize to casein kinase 2 nucleic acid sequences and methods of using such antisense oligonucleotides to inhibit expression of casein kinase 2 and reduce the size of solid tumors.
    Type: Application
    Filed: June 14, 2007
    Publication date: May 15, 2008
    Inventors: Joel W. Slaton, Khalil Ahmed, Gretchen M. Unger, Alan Davis, Dan Sloper